UBS Group
TTPH

UBS Group’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

UBS Group’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-315
Closed -$231K – 9002
2015
Q1 		$231K Hold
315
– – ﹤0.01% 4767
2014
Q4 		$250K Buy
+315
New +$170K ﹤0.01% 4827

UBS Group's TTPH Position: Q3 2020 in Review

UBS Group sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2020, closing a stake of 2,925 shares — an estimated $7K sold.

UBS Group first reported a position in TTPH in Q4 2014 and held it in 21 quarters. The position peaked at $1.83M in Q2 2015. 1 fund tracked by Wall St. Rank holds TTPH as of Q3 2020.

  • UBS Group reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • UBS Group sold 2,925 Tetraphase Pharmaceuticals, Inc. shares in Q3 2020, an estimated $7K.
  • UBS Group first reported a position in Tetraphase Pharmaceuticals, Inc. in Q4 2014 and held it in 21 quarters.
  • UBS Group's Tetraphase Pharmaceuticals, Inc. position peaked at $1.83M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2020.

Based on UBS Group's 13F filing for Q3 2020, filed 12 Nov 2020.